CD8+ T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain

Susmita K. Singh(The University of Texas MD Anderson Cancer Center), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center)

JCI Insight

March 7, 2022

10.1172/jci.insight.154194

Cited by 93

Related Papers

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

|Nature Medicine|2023|372

GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain

|Journal of Neuroscience|2010|106

Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain

|Journal of Clinical Investigation|2013|97

Low Nociceptor GRK2 Prolongs Prostaglandin E<sub>2</sub>Hyperalgesia via Biased cAMP Signaling to Epac/Rap1, Protein Kinase Cε, and MEK/ERK

|Journal of Neuroscience|2010|88

G Protein-Coupled Receptor Kinase 6 Acts as a Critical Regulator of Cytokine-Induced Hyperalgesia by Promoting Phosphatidylinositol 3-Kinase and Inhibiting p38 Signaling

|Molecular Medicine|2012|27